AIC
GCVRZ

Ayalon Insurance Company’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Ayalon Insurance Company’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$0 Buy
+7
New +$2 ﹤0.01% 85
2016
Q3 		– Sell
-7
Closed – – 92
2016
Q2 		$0 Hold
7
– – ﹤0.01% 105
2016
Q1 		$0 Hold
7
– – ﹤0.01% 138
2015
Q4 		$0 Hold
7
– – ﹤0.01% 147
2015
Q3 		$0 Hold
7
– – ﹤0.01% 162
2015
Q2 		$0 Hold
7
– – ﹤0.01% 185
2015
Q1 		$0 Buy
+7
New +$5 ﹤0.01% 177

Other funds holding GCVRZ

SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.82% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return

Ayalon Insurance Company's GCVRZ Position: Q4 2016 in Review

Ayalon Insurance Company opened a new position in Sanofi Contingent Value Rights (GCVRZ) in Q4 2016: 7 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #85 among its holdings. This is a return to the name: Ayalon Insurance Company previously reported a position in GCVRZ as recently as Q2 2016.

Ayalon Insurance Company first reported a position in GCVRZ in Q1 2015 and has held it in 7 quarters since. 120 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2016.

  • Ayalon Insurance Company held 7 shares of Sanofi Contingent Value Rights worth $0 as of Q4 2016.
  • Sanofi Contingent Value Rights was a new Ayalon Insurance Company position in Q4 2016.
  • Sanofi Contingent Value Rights made up ﹤0.01% of Ayalon Insurance Company's portfolio in Q4 2016, its #85 holding.
  • Ayalon Insurance Company first reported a position in Sanofi Contingent Value Rights in Q1 2015 and has held it in 7 quarters since.
  • 120 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2016.

Based on Ayalon Insurance Company's 13F filing for Q4 2016, filed 13 Feb 2017.